Strategic purchasing of oncology drugs to improve affordability and access to cancer care in India
{{output}}
Cancer is a leading driver of catastrophic health expenditure in India, where medicines constitute more than 60% of out-of-pocket expenditure. Fragmented procurement, inefficient supply chains, market-based pricing, and limited public coverage of novel high-co... ...
